Vamorolone is a dissociative corticosteroid medication primarily indicated for the treatment of Duchenne muscular dystrophy, designed to offer anti-inflammatory and immunosuppressive effects while potentially… Read more




Vamorolone is a dissociative corticosteroid medication primarily indicated for the treatment of Duchenne muscular dystrophy, designed to offer anti-inflammatory and immunosuppressive effects while potentially mitigating some of the side effects associated with traditional glucocorticoids. This category provides essential reference standards, including the active pharmaceutical ingredient, related process-related impurities, and metabolic derivatives such as glucuronide conjugates. Pharmaceutical laboratories utilize these materials for impurity profiling, method validation, and rigorous quality control testing to ensure the integrity and safety of drug formulations. Additionally, stable isotope labelled versions of Vamorolone are available, which serve as critical internal standards for quantitative mass spectrometry, enabling precise assessment of metabolic pathways and pharmacokinetic studies. By providing access to these high-quality standards, analytical teams can effectively monitor impurity levels and ensure compliance with regulatory standards throughout the drug development and manufacturing lifecycle.